We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Intestinal inflammation targets cancer-inducing activity of the microbiota.

Science (New York, N.Y.) | Oct 5, 2012

Inflammation alters host physiology to promote cancer, as seen in colitis-associated colorectal cancer (CRC). Here, we identify the intestinal microbiota as a target of inflammation that affects the progression of CRC. High-throughput sequencing revealed that inflammation modifies gut microbial composition in colitis-susceptible interleukin-10-deficient (Il10(-/-)) mice. Monocolonization with the commensal Escherichia coli NC101 promoted invasive carcinoma in azoxymethane (AOM)-treated Il10(-/-) mice. Deletion of the polyketide synthase (pks) genotoxic island from E. coli NC101 decreased tumor multiplicity and invasion in AOM/Il10(-/-) mice, without altering intestinal inflammation. Mucosa-associated pks(+) E. coli were found in a significantly high percentage of inflammatory bowel disease and CRC patients. This suggests that in mice, colitis can promote tumorigenesis by altering microbial composition and inducing the expansion of microorganisms with genotoxic capabilities.

Pubmed ID: 22903521 RIS Download

Mesh terms: Animals | Azoxymethane | Carcinogens | Carcinoma | Cell Transformation, Neoplastic | Colitis | Colorectal Neoplasms | DNA Damage | Escherichia coli | Interleukin-10 | Intestines | Metagenome | Mice | Mice, Mutant Strains | Polyketide Synthases | Sequence Deletion

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: NIDDK NIH HHS, Id: R01 DK073338
  • Agency: NIDDK NIH HHS, Id: R01 DK047700
  • Agency: NIDDK NIH HHS, Id: P30 DK034987
  • Agency: NCI NIH HHS, Id: P30 CA016086
  • Agency: PHS HHS, Id: P40 R018603
  • Agency: NIDDK NIH HHS, Id: R01 DK53347-11
  • Agency: NIDDK NIH HHS, Id: R01 DK053347
  • Agency: NIDDK NIH HHS, Id: R01 DK47700
  • Agency: Canadian Institutes of Health Research, Id: MOP114872
  • Agency: NCI NIH HHS, Id: R01 CA136887
  • Agency: NIDDK NIH HHS, Id: T32 DK007737
  • Agency: NIDDK NIH HHS, Id: R01 DK73338

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.